Skip to main content
BeOne Medicines AG (HKG:6160)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
179.20
+0.30 (0.17%)
Apr 29, 2026, 4:08 PM HKT

BeOne Medicines AG Revenue

In the year 2025, BeOne Medicines AG had annual revenue of $5.34B USD with 40.23% growth. BeOne Medicines AG had revenue of $1.50B in the quarter ending December 31, 2025, with 32.84% growth.

Revenue
$5.34B
Revenue Growth
+40.23%
P/S Ratio
6.24
Revenue / Employee
$445.25K
Employees
12,000
Market Cap
259.65B HKD

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20255.34B1.53B40.23%
Dec 31, 20243.81B1.35B54.96%
Dec 31, 20232.46B1.04B73.65%
Dec 31, 20221.42B239.64M20.37%
Dec 31, 20211.18B867.41M280.83%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Innovent Biologics 14.51B
WuXi Biologics 24.25B
Akeso 3.40B
Sichuan Kelun-Biotech Biopharmaceutical 2.29B
Sino Biopharmaceutical 35.43B
RemeGen 3.62B
3SBio 19.69B
Biocytogen Pharmaceuticals (Beijing) 1.53B
Revenue Rankings

BeOne Medicines AG News

More News